Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KRYS

Krystal Biotech Inc

May 08 • 04:00PM ET

305.71

+9.01 3.04 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: SRPT CRSP NTLA BEAM QURE

| Held by: IJR VTI IWM VB XBI FBT VBK VXF SPSM IJT

Scroll to Statements

Index	RUT	P/E	40.86	EPS (ttm)	7.48	Insider Own	13.09%	Shs Outstand	29.44M	Perf Week	14.91%
Market Cap	9.01B	Forward P/E	31.48	EPS next Y	9.71	Insider Trans	-6.18%	Shs Float	25.62M	Perf Month	18.34%
Enterprise Value	8.20B	PEG	1.36	EPS next Q	1.79	Inst Own	94.96%	Short Float	11.37%	Perf Quarter	12.09%
Income	225.03M	P/S	21.60	EPS this Y	13.33%	Inst Trans	-1.47%	Short Ratio	9.97	Perf Half Y	52.95%
Sales	417.30M	P/B	7.05	EPS next Y	25.28%	ROA	18.21%	Short Interest	2.91M	Perf YTD	24.00%
Book/sh	43.37	P/C	10.95	EPS next 5Y	23.11%	ROE	19.90%	52W High	303.00 0.89%	Perf Year	122.87%
Cash/sh	27.93	P/FCF	37.97	EPS past 3/5Y	- -	ROIC	17.53%	52W Low	122.80 148.95%	Perf 3Y	248.78%
Dividend Est.	-	EV/EBITDA	44.25	Sales past 3/5Y	- -	Gross Margin	92.72%	Volatility	7.15% 4.29%	Perf 5Y	331.92%
Dividend TTM	-	EV/Sales	19.65	EPS Y/Y TTM	79.56%	Oper. Margin	42.81%	ATR (14)	12.47	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.06	Sales Y/Y TTM	25.15%	Profit Margin	53.92%	RSI (14)	71.66	Recom	1.17
Dividend Gr. 3/5Y	- -	Current Ratio	9.46	EPS Q/Q	53.27%	SMA20	11.11%	Beta	0.49	Target Price	326.00
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	31.95%	SMA50	15.78%	Rel Volume	1.61	Prev Close	296.70
Employees	295	LT Debt/Eq	0.01	Earnings	May 04 BMO	SMA200	38.15%	Avg Volume	292.22K	Price	305.71
IPO	Sep 20, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.80% 3.79%	Trades		Volume	470,725	Change	3.04%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)